Rapid Therapeutic Science Laboratories, Inc. (RTSL) is a publicly traded company in the Unknown sector. Across all available filings, 2 corporate insiders have executed 10 transactions totaling $2.3M, demonstrating a bearish sentiment with -$2.3M in net insider flow. The most recent transaction on Dec 27, 2021 involved a transaction of 2,000,000 shares valued at $520.0K.
No significant insider buying has been recorded for RTSL in the recent period.
No significant insider selling has been recorded for RTSL in the recent period.
Based on recent SEC filings, insider sentiment for RTSL is bearish with an Insider Alignment Score of 0/100 and a net flow of -$2.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Rapid Therapeutic Science Laboratories, Inc. (RTSL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 2 insiders are actively trading RTSL stock, having executed 10 transactions in the past 90 days. The most active insider is Donal Ray Schmidt Jr (Executive), who has made 6 transactions totaling $1.7M.
Get notified when executives and directors at RTSL file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 27, 2021 | Ray Schmidt Donal Jr | Executive | Gift | 2,000,000 | $0.26 | $520.0K | Large |
| Dec 27, 2021 | Paul Berrier Sean | Executive | Gift | 2,000,000 | $0.26 | $520.0K | Large |
| Dec 28, 2020 | Ray Schmidt Donal Jr | Executive | Sale | 1,666,667 | $0.30 | $500.0K | Large |
| Dec 28, 2020 | Ray Schmidt Donal Jr | Executive | Sale | 2,000,000 | $0.25 | $500.0K | Large |
| Dec 28, 2020 | Paul Berrier Sean | Executive | Sale | 600,000 | $0.25 | $150.0K | |
| Dec 22, 2020 | Ray Schmidt Donal Jr | Executive | Sale | 600,000 | $0.25 | $150.0K | |
| Dec 22, 2020 | Paul Berrier Sean | Executive | Sale | 1,666,667 | $0.30 | $500.0K | Large |
| Dec 22, 2020 | Paul Berrier Sean | Executive | Sale | 2,000,000 | $0.25 | $500.0K | Large |
| Dec 2, 2020 | Ray Schmidt Donal Jr | Executive | Other | 0 | $N/A | $0 | |
| Dec 2, 2020 | Ray Schmidt Donal Jr | Executive | Other | 54,600,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 6 | $2.3M | 68.9% |
Gift(G) | 2 | $1.0M | 31.1% |
Other(J) | 2 | $0 | 0.0% |
Insider selling pressure at Rapid Therapeutic Science Laboratories, Inc. has increased, with 2 insiders executing 10 transactions across all time. Total sales of $2.3M significantly outpace purchases of $0, resulting in a net outflow of $2.3M. This selling activity appears largely discretionary, which may warrant closer attention from investors.